Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice

Sabrina Chiloiro, Tommaso Tartaglione, Ettore Domenico Capoluongo, Filippo Russo

Research output: Contribution to journalArticle

Abstract

Hypophysitis is a rare and potentially life-threatening disease, characterized by an elevated risk of complications, such as the occurrence of acute central hypoadrenalism, persistent hypopituitarism, or the extension of the inflammatory process to the neighboring neurological structures. In recent years, a large number of cases has been described. The diagnosis of hypophysitis is complex because it is based on clinical and radiological criteria. Due to this, the integration of molecular and genetic biomarkers can help physicians in the diagnosis of hypophysitis and play a role in predicting disease outcome. In this paper, we review current knowledge about molecular and genetic biomarkers of hypophysitis with the aim of suggesting a possible integration of these biomarkers in clinical practice.
Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalJournal of Personalized Medicine
Publication statusPublished - 2021

Keywords

  • CTLA-4
  • HLA
  • MHC

Fingerprint

Dive into the research topics of 'Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice'. Together they form a unique fingerprint.

Cite this